{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:56Z","timestamp":1791843236041,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (PHPT) is most commonly sporadic (sPHPT). However, sometimes PHPT develops as part of multiple endocrine neoplasia (MEN) type 1 or 2A. In all, parathyroidectomy is the only curative treatment. Nevertheless, there are important differences in clinical expression and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a consecutive cohort of patients treated for sporadic, MEN1-related, and MEN2A-related PHPT and compared them regarding clinical and biochemical parameters, differences in preoperative workup, operative strategies, findings, and outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 467 patients with sPHPT, 52 with MEN1- and 16 with MEN2A-related PHPT were analyzed. Patients with sPHPT were older, more often female and had higher preoperative calcium and parathyroid hormone levels, when compared with MEN1 and MEN2A patients. Minimally invasive parathyroidectomy (MIP) was performed in 367 of 467 sPHPT patients (79%). One abnormal parathyroid was found in 426 patients (91%). Two or more in 35 patients (7%). In six patients (1%) no abnormal parathyroid gland was retrieved. Of 52 MEN1 patients, eight (15%) underwent a MIP and 44 patients (85%) underwent conventional neck exploration (CNE); with resection of fewer than 3\u00bd enlarged glands in 21 patients (40%), subtotal parathyroidectomy (SPTX, 3-3\u00bd glands) in seventeen (33%) and total parathyroidectomy with autotransplantation (TPTX) in six (12%). Eleven patients (21%) had persistent disease, 29 (56%) recurrent PHPT and nine (17%) permanent hypoparathyroidism, mostly after TPTX. Of 16 MEN2A patients, six (38%) underwent MIP, four (25%) CNE and six (38%) selective resection of the enlarged gland(s) during total thyroidectomy. Three patients (19%) suffered from persistent PHPT and two (13%) developed recurrent disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sporadic PHPT, MEN1- and MEN2A-related PHPT are three distinct entities as is reflected preoperatively by differences in gender, age at diagnosis and calcium and PTH levels.<\/jats:p>\n                    <jats:p>MEN2A patients are very similar to sPHPT with respect to operative approach and findings. MIP is the treatment of choice for both. MIP has low rates of persistent and recurrent PHPT and a low complication rate. The percentage of multiglandular disease and recurrences are significantly higher in MEN1 patients, demonstrating the need for a different approach. We advocate treating these patients with CNE and SPTX.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1750-1172-8-50","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T14:14:05Z","timestamp":1364825645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up"],"prefix":"10.1186","volume":"8","author":[{"given":"Bas A","family":"Twigt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inne HM Borel","family":"Rinkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"issue":"Suppl 2","key":"542_CR1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/jbmr.5650061409","volume":"6","author":"LJ Melton III","year":"1991","unstructured":"Melton LJ: Epidemiology of primary hyperparathyroidism. J Bone Miner Res. 1991, 6 (Suppl 2): S25-S30.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"542_CR2","doi-asserted-by":"publisher","first-page":"21s","DOI":"10.1016\/S0753-3322(00)80006-2","volume":"54","author":"H Takami","year":"2000","unstructured":"Takami H, Shirahama S, Ikeda Y, Sasaki Y, Wada N, Niimi M: Familial hyperparathyroidism. Biomed Pharmacother. 2000, 54 (Suppl 1): 21s-24s.","journal-title":"Biomed Pharmacother"},{"key":"542_CR3","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001, 86: 5658-5671. 10.1210\/jc.86.12.5658.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1067\/msy.1998.93107","volume":"124","author":"SE Carty","year":"1998","unstructured":"Carty SE, Helm AK, Amico JA, Clarke MR, Foley TP, Watson CG: The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery. 1998, 124: 1106-1113. 10.1067\/msy.1998.93107.","journal-title":"Surgery"},{"key":"542_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","volume":"255","author":"CR Pieterman","year":"2012","unstructured":"Pieterman CR, van Hulsteijn LT, den HM, van der Luijt RB, Bonenkamp JJ, Hermus AR: Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012, 255: 1171-1178. 10.1097\/SLA.0b013e31824c5145.","journal-title":"Ann Surg"},{"key":"542_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM199409293311302","volume":"331","author":"CJ Lips","year":"1994","unstructured":"Lips CJ, Landsvater RM, Hoppener JW, Geerdink RA, Blijham G, van Veen JM: Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 1994, 331: 828-835. 10.1056\/NEJM199409293311302.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"542_CR7","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C: Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res. 2002, 17 (Suppl 2): N37-N43.","journal-title":"J Bone Miner Res"},{"key":"542_CR8","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/jbmr.125","volume":"25","author":"DM Lourenco Jr","year":"2010","unstructured":"Lourenco DM, Coutinho FL, Toledo RA, Montenegro FL, Correia-Deur JE, Toledo SP: Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J Bone Miner Res. 2010, 25: 2382-2391. 10.1002\/jbmr.125.","journal-title":"J Bone Miner Res"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.090304","volume":"24","author":"C Eller-Vainicher","year":"2009","unstructured":"Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S: Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res. 2009, 24: 1404-1410. 10.1359\/jbmr.090304.","journal-title":"J Bone Miner Res"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-2001-16944","volume":"33","author":"M Katai","year":"2001","unstructured":"Katai M, Sakurai A, Ikeo Y, Hashizume K: Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res. 2001, 33: 499-503. 10.1055\/s-2001-16944.","journal-title":"Horm Metab Res"},{"issue":"Suppl 1","key":"542_CR11","doi-asserted-by":"publisher","first-page":"86s","DOI":"10.1016\/S0753-3322(00)80020-7","volume":"54","author":"M Sato","year":"2000","unstructured":"Sato M, Miyauchi A, Takahara J: Clinical aspects of hyperparathyroidism in Japanese multiple endocrine neoplasia type 1. Biomed Pharmacother. 2000, 54 (Suppl 1): 86s-89s.","journal-title":"Biomed Pharmacother"},{"key":"542_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","volume":"54","author":"JP Bilezikian","year":"2010","unstructured":"Bilezikian JP, Silverberg SJ: Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol. 2010, 54: 106-109. 10.1590\/S0004-27302010000200004.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"542_CR13","first-page":"301","volume":"10","author":"JP Gardin","year":"1984","unstructured":"Gardin JP, Paillard M: Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium. Miner Electrolyte Metab. 1984, 10: 301-308.","journal-title":"Miner Electrolyte Metab"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P: Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab. 2003, 88: 4641-4648. 10.1210\/jc.2002-021404.","journal-title":"J Clin Endocrinol Metab"},{"key":"542_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-12-0210","volume":"167","author":"JM de Laat","year":"2012","unstructured":"de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML: Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. Eur J Endocrinol. 2012, 167: 181-187.","journal-title":"Eur J Endocrinol"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00000658-200004000-00016","volume":"231","author":"PC Smit","year":"2000","unstructured":"Smit PC, Borel RI, van DA, van Vroonhoven TJ: Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration?. Ann Surg. 2000, 231: 559-565. 10.1097\/00000658-200004000-00016.","journal-title":"Ann Surg"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00423-009-0510-z","volume":"394","author":"M Barczynski","year":"2009","unstructured":"Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W: Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg. 2009, 394: 843-849. 10.1007\/s00423-009-0510-z.","journal-title":"Langenbecks Arch Surg"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.surg.2003.06.001","volume":"134","author":"DM Carneiro","year":"2003","unstructured":"Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL: Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery. 2003, 134: 973-979. 10.1016\/j.surg.2003.06.001.","journal-title":"Surgery"},{"key":"542_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/0002-9343(79)91062-3","volume":"66","author":"CB Lamers","year":"1979","unstructured":"Lamers CB, Froeling PG: Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I). Am J Med. 1979, 66: 422-424. 10.1016\/0002-9343(79)91062-3.","journal-title":"Am J Med"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1072-7515(03)00108-X","volume":"196","author":"H Genc","year":"2003","unstructured":"Genc H, Morita E, Perrier ND, Miura D, Ituarte P, Duh QY: Differing histologic findings after bilateral and focused parathyroidectomy. J Am Coll Surg. 2003, 196: 535-540. 10.1016\/S1072-7515(03)00108-X.","journal-title":"J Am Coll Surg"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archsurg.137.8.896","volume":"137","author":"NC Lee","year":"2002","unstructured":"Lee NC, Norton JA: Multiple-gland disease in primary hyperparathyroidism: a function of operative approach?. Arch Surg. 2002, 137: 896-899. 10.1001\/archsurg.137.8.896.","journal-title":"Arch Surg"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1245\/s10434-010-1394-4","volume":"18","author":"BA Twigt","year":"2011","unstructured":"Twigt BA, Vollebregt AM, van DT, Smits AB, Consten EC, van Vroonhoven TJ: Shifting incidence of solitary adenomas in the era of minimally invasive parathyroidectomy. A multi-institutional study. Ann Surg Oncol. 2011, 18: 1041-1046. 10.1245\/s10434-010-1394-4.","journal-title":"Ann Surg Oncol"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jamcollsurg.2006.10.034","volume":"204","author":"A Gil-Cardenas","year":"2007","unstructured":"Gil-Cardenas A, Gamino R, Reza A, Pantoja JP, Herrera MF: Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy?. J Am Coll Surg. 2007, 204: 286-290. 10.1016\/j.jamcollsurg.2006.10.034.","journal-title":"J Am Coll Surg"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00268-004-7469-2","volume":"28","author":"SR Jacobson","year":"2004","unstructured":"Jacobson SR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Mullan BP: Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg. 2004, 28: 1127-1131. 10.1007\/s00268-004-7469-2.","journal-title":"World J Surg"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/bjs.5574","volume":"94","author":"R Mihai","year":"2007","unstructured":"Mihai R, Palazzo FF, Gleeson FV, Sadler GP: Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg. 2007, 94: 42-47. 10.1002\/bjs.5574.","journal-title":"Br J Surg"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amjsurg.2005.10.003","volume":"191","author":"DW Ollila","year":"2006","unstructured":"Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE: Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg. 2006, 191: 52-56. 10.1016\/j.amjsurg.2005.10.003.","journal-title":"Am J Surg"},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/bjs.5608","volume":"94","author":"T Pang","year":"2007","unstructured":"Pang T, Stalberg P, Sidhu S, Sywak M, Wilkinson M, Reeve TS: Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring. Br J Surg. 2007, 94: 315-319. 10.1002\/bjs.5608.","journal-title":"Br J Surg"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jamcollsurg.2006.03.022","volume":"203","author":"P Stalberg","year":"2006","unstructured":"Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L: Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it \"value-add\" to decision-making?. J Am Coll Surg. 2006, 203: 1-6. 10.1016\/j.jamcollsurg.2006.03.022.","journal-title":"J Am Coll Surg"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjsurg.2011.07.017","volume":"204","author":"BA Twigt","year":"2012","unstructured":"Twigt BA, van DT, Vollebregt AM, Kortlandt W, Vriens MR, Borel RI: The additional value of intraoperative parathyroid hormone assessment is marginal in patients with nonfamilial primary hyperparathyroidism: a prospective cohort study. Am J Surg. 2012, 204: 1-6. 10.1016\/j.amjsurg.2011.07.017.","journal-title":"Am J Surg"},{"key":"542_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.surg.2005.06.046","volume":"138","author":"H Chen","year":"2005","unstructured":"Chen H, Pruhs Z, Starling JR, Mack E: Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005, 138: 583-587. 10.1016\/j.surg.2005.06.046.","journal-title":"Surgery"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00268-002-6619-7","volume":"26","author":"WB Inabnet III","year":"2002","unstructured":"Inabnet WB, Dakin GF, Haber RS, Rubino F, Diamond EJ, Gagner M: Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg. 2002, 26: 921-925. 10.1007\/s00268-002-6619-7.","journal-title":"World J Surg"},{"key":"542_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00268-004-7708-6","volume":"28","author":"GL Irvin III","year":"2004","unstructured":"Irvin GL, Solorzano CC, Carneiro DM: Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004, 28: 1287-1292. 10.1007\/s00268-004-7708-6.","journal-title":"World J Surg"},{"key":"542_CR33","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1365-2265.2007.02827.x","volume":"66","author":"M Barczynski","year":"2007","unstructured":"Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B: Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf). 2007, 66: 878-885. 10.1111\/j.1365-2265.2007.02827.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"542_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1001\/archotol.130.1.87","volume":"130","author":"EJ Bergson","year":"2004","unstructured":"Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS: Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg. 2004, 130: 87-91. 10.1001\/archotol.130.1.87.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/00000658-199906000-00015","volume":"229","author":"GL Irvin III","year":"1999","unstructured":"Irvin GL, Molinari AS, Figueroa C, Carneiro DM: Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg. 1999, 229: 874-878. 10.1097\/00000658-199906000-00015.","journal-title":"Ann Surg"},{"key":"542_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/archsurg.133.2.126","volume":"133","author":"JR Burgess","year":"1998","unstructured":"Burgess JR, David R, Parameswaran V, Greenaway TM, Shepherd JJ: The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 1998, 133: 126-129. 10.1001\/archsurg.133.2.126.","journal-title":"Arch Surg"},{"key":"542_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.otc.2004.02.005","volume":"37","author":"JP Malone","year":"2004","unstructured":"Malone JP, Srivastava A, Khardori R: Hyperparathyroidism and multiple endocrine neoplasia. Otolaryngol Clin North Am. 2004, 37: 715-736. 10.1016\/j.otc.2004.02.005. viii","journal-title":"Otolaryngol Clin North Am"},{"key":"542_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","volume":"246","author":"F Tonelli","year":"2007","unstructured":"Tonelli F, Marcucci T, Fratini G, Tommasi MS, Falchetti A, Brandi ML: Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?. Ann Surg. 2007, 246: 1075-1082. 10.1097\/SLA.0b013e31811f4467.","journal-title":"Ann Surg"},{"key":"542_CR39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","volume":"134","author":"DM Elaraj","year":"2003","unstructured":"Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF: Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003, 134: 858-864. 10.1016\/S0039-6060(03)00406-9.","journal-title":"Surgery"},{"key":"542_CR40","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/BF02067367","volume":"16","author":"P Hellman","year":"1992","unstructured":"Hellman P, Skogseid B, Juhlin C, Akerstrom G, Rastad J: Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1. World J Surg. 1992, 16: 718-722. 10.1007\/BF02067367.","journal-title":"World J Surg"},{"key":"542_CR41","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0039-6060(98)70040-6","volume":"124","author":"P Hellman","year":"1998","unstructured":"Hellman P, Skogseid B, Oberg K, Juhlin C, Akerstrom G, Rastad J: Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998, 124: 993-999. 10.1016\/S0039-6060(98)70040-6.","journal-title":"Surgery"},{"key":"542_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/archsurg.141.3.235","volume":"141","author":"JG Hubbard","year":"2006","unstructured":"Hubbard JG, Sebag F, Maweja S, Henry JF: Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg. 2006, 141: 235-239. 10.1001\/archsurg.141.3.235.","journal-title":"Arch Surg"},{"key":"542_CR43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","volume":"140","author":"LA Lambert","year":"2005","unstructured":"Lambert LA, Shapiro SE, Lee JE, Perrier ND, Truong M, Wallace MJ: Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg. 2005, 140: 374-382. 10.1001\/archsurg.140.4.374.","journal-title":"Arch Surg"},{"key":"542_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1245\/ASO.2006.12.009","volume":"13","author":"CH Lee","year":"2006","unstructured":"Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH: Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol. 2006, 13: 103-109. 10.1245\/ASO.2006.12.009.","journal-title":"Ann Surg Oncol"},{"key":"542_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/BF01655552","volume":"10","author":"J Malmaeus","year":"1986","unstructured":"Malmaeus J, Benson L, Johansson H, Ljunghall S, Rastad J, Akerstrom G: Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure. World J Surg. 1986, 10: 668-672. 10.1007\/BF01655552.","journal-title":"World J Surg"},{"key":"542_CR46","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","volume":"35","author":"JM Schreinemakers","year":"2011","unstructured":"Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD, Rinkes IH: The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg. 2011, 35: 1993-2005. 10.1007\/s00268-011-1068-9.","journal-title":"World J Surg"},{"key":"542_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4158\/EP10050.OR","volume":"17","author":"A Scholten","year":"2011","unstructured":"Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel RI: Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract. 2011, 17: 7-15.","journal-title":"Endocr Pract"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-8-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:35:55Z","timestamp":1715132155000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-8-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-8-50","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]},"assertion":[{"value":"3 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}